Workflow
GUANGDONG HONGTU(002101)
icon
Search documents
广东鸿图(002101) - 第八届董事会第五十七次会议决议公告
2025-06-05 12:45
证券代码:002101 证券简称:广东鸿图 公告编号:2025-34 广东鸿图科技股份有限公司 表决结果:同意 8 票,反对 0 票,弃权 0 票。 第八届董事会第五十七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 广东鸿图科技股份有限公司(以下简称"公司"或"本公司")第八届董事会第五 十七次会议通知于2025年5月27日通过短信、电子邮件等形式向全体董事发出。会议于 2025年6月5日以通讯表决方式召开,会议应参与表决董事8人,实际参与表决董事8人。 会议的召集、召开符合《公司法》及本公司章程的有关规定,会议合法有效。会议采用 投票表决的方式审议了相关议案并作出如下决议: 一、审议通过了《关于提请召开 2024 年度股东大会的议案》。 具体内容详见公司 2025 年 6 月 6 日刊登于巨潮资讯网的《关于召开 2024 年度股 东大会的通知》。 二〇二五年六月六日 1 特此公告。 广东鸿图科技股份有限公司 董事会 ...
5月27日晚间重要公告一览
Xi Niu Cai Jing· 2025-05-27 10:16
Group 1 - Guangdian Electric's wholly-owned subsidiary plans to sell 5.91% stake in Shanghai Winshun Electric Technology Co., Ltd. to Yapp Automotive Parts Co., Ltd. for 62.63 million yuan, aiming to optimize asset structure [1] - Anhui Natural Gas received approval for the registration of 500 million yuan short-term financing bonds and 600 million yuan medium-term notes, valid for two years [1] - Kirin Security received government subsidies totaling 6.48 million yuan, which are related to revenue [2] Group 2 - Junshi Biosciences received approval for two new indications for its self-developed drug, Oncorhynchus monoclonal antibody injection, targeting adult patients with heterozygous familial hypercholesterolemia and non-familial hypercholesterolemia [3] - China Resources Double Crane's subsidiary passed GMP compliance inspection for small and large volume injection production lines [4] - Nanjing Public Utilities' board approved the absorption and merger of its wholly-owned subsidiary, Nanjing Jinguang Industry Co., Ltd. [7] Group 3 - Boya Bio received drug registration certificate for human immunoglobulin (pH4) in the Dominican Republic, valid until August 12, 2029 [8] - Jizhi Co. announced that its controlling shareholder and actual controller committed not to reduce their shareholdings until December 31, 2025 [9] - Yuhua Tian won a bid for the integrated urban management project in Lanzhou City, with a total service subsidy of 353 million yuan [10] Group 4 - Anke Rui obtained five invention patent certificates related to various energy management and control technologies [11] - Kebo Da's wholly-owned subsidiary plans to acquire 100% of Czech IMI Company for approximately 9.43 million euros to enhance global production layout [13] - Yantian Port announced a cash dividend of 1.30 yuan per 10 shares, totaling 676 million yuan [14] Group 5 - Huawang Technology plans to distribute a cash dividend of 0.45 yuan per share and a capital reserve increase of 0.20 shares per share [15] - Kabe Yi established a wholly-owned subsidiary in Japan to enhance its business layout [16] - Dongcheng Pharmaceutical's subsidiary received approval for the marketing of sodium fluoride injection, a PET radiopharmaceutical [18] Group 6 - Huaxin New Materials' subsidiary received two utility model patent certificates for innovative devices [19] - Lingang Steel's new 2290 cubic meter blast furnace has been successfully put into operation [21] - Xinlitai received drug registration certificate for Sacubitril/Valsartan tablets, the first of its kind in China [23] Group 7 - Aike Co.'s subsidiary received project designation notices from multiple clients for electric drive platform components [25] - Tonghe Pharmaceutical received drug registration certificate for Apixaban in South Korea [26] - Junting Hotel signed a cooperation agreement with Choice Hotels for exclusive brand usage in mainland China [28] Group 8 - Guangdong Hongtu plans to establish a wholly-owned subsidiary in Zhengzhou to enhance market layout [30] - Yuheng Pharmaceutical signed a joint promotion agreement for Pemafibrate tablets with Xinghe Pharmaceutical [31] - Chongqing Steel terminated the absorption and merger of its wholly-owned subsidiary, citing strategic advantages of independent operation [33] Group 9 - Jihong Co. announced the listing of its H-shares on the Hong Kong Stock Exchange [34] - Deshi Co. announced plans for shareholders to reduce their holdings by up to 0.3% [36] - Xinhai Medical's subsidiary received medical device registration for a dialysis fluid filter [42]
广东鸿图: 第八届董事会第五十六次会议决议公告
Zheng Quan Zhi Xing· 2025-05-27 04:12
证券代码:002101 证券简称:广东鸿图 公告编号:2025-32 广东鸿图科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 广东鸿图科技股份有限公司(以下简称"公司"或"本公司")第八届董事会第五 十六次会议通知于2025年5月20日通过短信、电子邮件等形式向全体董事、监事发出。 会议于2025年5月25日以现场与网络会议相结合方式召开,会议应出席(参与表决)董 事8人,实际出席董事8人。会议的召集、召开符合《公司法》及本公司章程的有关规定, 会议合法有效。会议由副董事长廖坚先生主持,采用投票表决的方式审议了相关议案并 作出如下决议: 一、审议通过了《关于全资子公司宁波四维尔收购力森诺科汽车配件(郑州)有限 公司资产的议案》; 董事会同意: 表决结果:同意 7 票,反对 0 票,弃权 1 票(董事罗旭强弃权,原因:市场环境不 明朗,基于审慎原则,对本次投资事项投弃权票)。 特此公告。 广东鸿图科技股份有限公司 董事会 二〇二五年五月二十七日 市设立一家全资子公司。 本次新设子公司的具体情况详见公司 2025 年 5 月 27 日刊登于巨潮资 ...
广东鸿图: 关于投资设立二级全资子公司的公告
Zheng Quan Zhi Xing· 2025-05-27 04:12
Group 1 - The company Guangdong Hongtu has approved the establishment of a wholly-owned subsidiary in Zhengzhou and the acquisition of assets from Lisenok Automotive Parts (Zhengzhou) Co., Ltd. [1] - The new subsidiary, named Zhengzhou Siweier, will focus on manufacturing and selling automotive parts, decorative components, and precision molds, as well as engaging in import and export activities [1] - The investment aims to enhance the company's market and production capacity layout in the Central China region, improve technological innovation capabilities, and optimize the product business structure [1] Group 2 - The establishment of Zhengzhou Siweier and the acquisition of Lisenok's assets will broaden and improve the company's regional market layout, contributing to the enhancement of production capacity and technical strength in the interior and exterior trim sectors [2] - The investment will be funded entirely by the company's own funds, ensuring that it does not significantly impact the company's financial status or operating results, and aligns with the interests of all shareholders [2]
5月27日午间公告一览:广东鸿图拟设立郑州子公司,注册资本不超3700万元
news flash· 2025-05-27 04:06
广东鸿图(002101)公告,公司全资子公司宁波四维尔工业有限责任公司将在郑州设立一家全资子公 司,注册资本不超过3700万元。该子公司将收购力森诺科汽车配件(郑州)有限公司的土地、房产和设备 等相关资产。此举旨在完善公司内外饰板块在华中地区的市场布局和产能布局,提升技术创新能力,优 化产品业务结构。郑州四维尔成立后将成为公司的二级全资子公司,资金来源为公司自有资金,对公司 财务状况和经营成果不会产生重大影响。 ...
广东鸿图(002101) - 第八届董事会第五十六次会议决议公告
2025-05-27 03:45
证券代码:002101 证券简称:广东鸿图 公告编号:2025-32 广东鸿图科技股份有限公司 第八届董事会第五十六次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 广东鸿图科技股份有限公司(以下简称"公司"或"本公司")第八届董事会第五 十六次会议通知于2025年5月20日通过短信、电子邮件等形式向全体董事、监事发出。 会议于2025年5月25日以现场与网络会议相结合方式召开,会议应出席(参与表决)董 事8人,实际出席董事8人。会议的召集、召开符合《公司法》及本公司章程的有关规定, 会议合法有效。会议由副董事长廖坚先生主持,采用投票表决的方式审议了相关议案并 作出如下决议: 一、审议通过了《关于全资子公司宁波四维尔收购力森诺科汽车配件(郑州)有限 公司资产的议案》; 2. 宁波四维尔在董事会审批通过的交易价格范围内,收购力森诺科汽车配件(郑 州)有限公司(简称"力森诺科")的土地厂房、设备等相关资产,其中由宁波四维尔 上述新设的郑州子公司收购力森诺科在郑州持有的土地、房产和设备等相关资产,由宁 波四维尔全资子公司武汉四维尔汽车零部件有限公司收购 ...
广东鸿图(002101) - 关于投资设立二级全资子公司的公告
2025-05-27 03:45
证券代码:002101 证券简称:广东鸿图 公告编号:2025-33 广东鸿图科技股份有限公司(以下简称"公司"或"本公司")第八届董事会第五 十六次会议审议通过了《关于全资子公司宁波四维尔收购力森诺科汽车配件(郑州)有 限公司资产的议案》,同意全资子公司宁波四维尔工业有限责任公司(简称"宁波四维 尔")在郑州设立一家全资子公司,收购力森诺科汽车配件(郑州)有限公司(简称"力 森诺科")在郑州所持有的土地、房产和设备等相关资产。 相关投资情况具体如下: 一、拟投资设立子公司的基本情况 1.公司名称:郑州四维尔汽车零部件有限公司(暂定名,以最终核准名称为准,以 下简称"郑州四维尔") 2.注册资本:不超过人民币3,700万元 3.注册地:郑州经济技术开发区(暂定) 4.经营范围:汽车用高性能复合树脂成形部件、轻量化树脂组装成形部件、金属模 具及以上产品所需零部件的制造及销售;汽车零部件、汽车装饰件、精密模具的制造及 销售;货物或技术进出口。涉及许可经营项目,应取得相关部门许可后方可经营。(以 最终核准范围为准) 广东鸿图科技股份有限公司 关于投资设立二级全资子公司的公告 本公司及董事会全体成员保证信息披露的内容 ...
广东鸿图(002101) - 002101广东鸿图投资者关系管理信息20250520
2025-05-20 14:30
Group 1: Business Overview - The company generated approximately 6 billion CNY in casting business revenue in 2024, accounting for 72.02% of total revenue [1] - The interior and exterior trim segment generated about 2.03 billion CNY, representing 25.25% of total revenue [1] - Major clients include Honda, Nissan, Toyota, General Motors, and several domestic and international automotive manufacturers [1] Group 2: Market Strategy - The company aims to maintain its market share with foreign and joint venture clients while increasing efforts to attract domestic brand clients, especially leading ones [2] - Despite the competitive environment leading to lower profit margins, the company will still pursue low-margin orders as they contribute to overall performance [2] Group 3: Production Capacity - The Guangzhou factory has invested in four large die-casting machines: one 16,000T, one 12,000T, and two 7,000T machines, primarily for producing components for new energy vehicles [3] - The production capacity of these machines is expected to increase, with revenue projected to grow year-on-year [3] Group 4: Raw Material Management - The company does not engage in futures market hedging for aluminum but locks prices directly with suppliers for aluminum liquid to control raw material costs [4] - The company has patented materials for integrated die-casting that do not require heat treatment, which is crucial for large products [4] Group 5: International Expansion - Overseas business accounts for approximately 18% of total revenue, primarily from exports to North America [5] - The company is actively exploring overseas capacity expansion, particularly in Southeast Asia and North America, although plans are subject to geopolitical uncertainties [5] Group 6: Future Directions - The company is focusing on investments in die-casting and interior/exterior trim segments, including new capacity overseas and vertical/horizontal industry chain expansions [5] - There are ongoing projects in emerging fields like low-altitude economy and robotics, with expectations for increased opportunities as these markets grow [5]
广东鸿图(002101) - 002101广东鸿图投资者关系管理信息20250513
2025-05-13 10:46
Group 1: Market Performance and Client Structure - The penetration rate of new energy vehicles has been increasing, leading to a 19.06% year-on-year revenue growth in Q1 2025, primarily driven by domestic independent brand clients [1] - The company's revenue from independent brands is gradually increasing, reflecting a positive market opportunity [1] Group 2: Large Die Casting Products Development - The company has installed 4 large die casting machines in its Guangzhou factory, including one 16,000T, one 12,000T, and two 7,000T machines, focusing on producing components for new energy vehicles [1][2] - The revenue share from these products is expected to increase significantly this year as production capacity ramps up [1] Group 3: Industry Trends and Challenges - Annual reductions in major manufacturers are normal, with product lifecycles typically ranging from 5 to 10 years, leading to improved capacity utilization and profit margins over time [3] - The company’s overseas business accounts for approximately 18% of total revenue, primarily from exports to North America, with various scenarios affecting tariff costs [4] Group 4: Strategic Planning and Future Investments - The company is actively planning overseas factory setups in Southeast Asia and North America, focusing on die casting and interior/exterior trim segments [4][5] - Future investments will center around expanding die casting and interior/exterior trim capabilities, including the purchase of 1-2 large die casting machines to meet customer demand [5] Group 5: New Business Areas and Goals - The company is exploring magnesium and titanium alloy technologies and conducting research in emerging fields like low-altitude economy and intelligent robotics [6] - Despite stable revenue growth, the company faces pressure on profitability due to intense competition and rising raw material costs, with a focus on cost reduction and efficiency improvements for 2024 [6][8]
广东鸿图(002101) - 方正证券承销保荐有限责任公司关于广东鸿图向特定对象发行股票持续督导保荐总结报告书
2025-05-07 10:16
方正证券承销保荐有限责任公司 关于广东鸿图科技股份有限公司 向特定对象发行股票持续督导保荐总结报告书 | | | 2、本保荐人及本人自愿接受中国证券监督管理委员会(简称"中国证监会") 对保荐总结报告书相关事项进行的任何质询和调查。 3、本保荐人及本人自愿接受中国证监会按照《证券发行上市保荐业务管理 办法》的有关规定采取的监管措施。 二、保荐人基本情况 1 | 保荐人 | 方正证券承销保荐有限责任公司 | | --- | --- | | 注册地址 | 北京市丰台区金丽南路 3 号院 2 号楼 1 至 16 层 01 内六层 1-203 室 | | 主要办公地址 | 北京市朝阳区朝阳门南大街 10 号兆泰国际中心 A 座 15 层 | | 法定代表人 | 孙斌 | | 保荐代表人 | 樊旭、钟亮亮 | | 联系电话 | 0755-36876480 方正证券承销保荐有限责任公司原委派樊旭先生、王军亮先生为该项 | | 是否更换保荐代 | 目保荐代表人;2023 年 12 月,由于王军亮先生工作调整,不能继续 | | 表人或其他情况 | 负责持续督导期的保荐工作,决定委派钟亮亮先生接替王军亮先生继 | | | 续履 ...